Discover

News & Info

Quote List Quote List

Citius Oncology(CTOR.US)

Event Tracking

Feb14

Citius Oncology released FY2026 Q1 earnings on February 13 (EST), actual revenue USD 3.944 M (forecast USD 4.373 M), actual EPS USD -0.0632 (forecast USD -0.04)

04:00

Dec26

Citius Oncology Faces Major Challenges in Commercializing LYMPHIR

06:02

Dec24

Citius Oncology released FY2025 annual earnings on December 23 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3379 (forecast USD -0.33)

04:00

Citius Oncology released FY2025 Q4 earnings on December 23 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0656 (forecast USD -0.06)

04:00

Oct7

Citius Oncology Establishes International Access for LYMPHIR™ in Southern Europe

12:48

Aug13

Citius Oncology released FY2025 9 Months Earnings on August 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.2762

03:00

Schedules & Filings

Schedules

Filings

Feb13

Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 3.944 M, Net Income -5.534 M, EPS -0.0632

Dec23

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -4.997 M, EPS -0.0637

Aug12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.37 M, EPS -0.075

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More